COVID-19: Oxford-AstraZeneca jab benefits outweigh 'rare incidents of risk', says vaccines minister - as regulator reviews clot cases

Tuesday 6th April 2021 11:45 BST


The benefits of taking the Oxford-AstraZeneca jab "far outweigh" any "rare incidents of risk", the vaccines minister has said, as the UK's drugs regulator investigates reports of blood clots.

The full article is no longer available.